Equine Healthcare Market
Equine Healthcare Market Forecasts to 2030 - Global Analysis By Product Type (Therapeutics, Diagnostics, Supplemental Nutrition and Other Product Types), Animal Type, Disease Type, Distribution Channel, End User and By Geography
According to Stratistics MRC, the Global Equine Healthcare Market is accounted for $3.6 billion in 2024 and is expected to reach $6.5 billion by 2030 growing at a CAGR of 10.3% during the forecast period. Equine healthcare is a specialized field that focuses on the health and well-being of horses through medical care, nutrition, and management practices. It includes routine veterinary care, such as vaccinations and dental exams, to prevent common diseases like colic, laminitis, and respiratory infections. Proper hoof care by farriers ensures horses' mobility and reduces lameness risk. Nutrition is a core component, with tailored diets balancing hay, grains, and supplements based on age, activity level, and health status. Exercise management is crucial for fitness, mental well-being, and injury prevention. Equine healthcare also addresses reproductive health, assisting with breeding, pregnancy, and foal care.
According to a February 2024 press release by Euro News, scientists from Costa Rica are involved in R&D to develop antidotes for human snake bites. They are utilizing the horses as the vessels to develop antibodies against the vaccine.
Market Dynamics:
Driver:
Rising incidence of equine diseases
Specialized horse healthcare services have increased as a result of the rise in equine diseases and the resulting demand for veterinary care, diagnosis, and treatments. Increased patient loads in hospitals and veterinary clinics are the main cause of this demand. Advanced diagnostic technologies are also in high demand due to the rising incidence of horse diseases and the need for precise diagnostic methods such blood tests, imaging tests, and genetic testing.
Restraint:
Limited access to veterinary care in rural areas
Rural areas lack access to veterinary services, resulting in fewer horse owners seeking regular care. This leads to a lower demand for equine healthcare products and services, limiting market penetration. Untreated diseases can also go undiagnosed or untreated, causing infections and severe conditions. Long recovery times and increased healthcare costs can be exacerbated. Therefore, timely veterinary intervention is crucial to mitigate these issues and improve the overall quality of life for horses in these areas.
Opportunity:
Heightened awareness regarding equine health among horse owners and veterinarians
Horse owners are increasingly seeking veterinary services due to increased awareness about equine health issues. This leads to a higher demand for routine check-ups, vaccinations, and specialized treatments. The market for preventive care, such as regular vaccinations and parasite control, is expected to grow as more horse owners prioritize their animals' health. This increased focus on preventive measures contributes to the growth of the market for vaccines, diagnostic tools, and other healthcare products designed to maintain equine health.
Threat:
Shortage of skilled veterinarians
As the number of practicing equine veterinarians decreases, horse owners face increasing difficulties in accessing timely veterinary care. Many clinics struggle to accommodate new clients, leading to longer wait times for appointments and emergency services. This limited access can result in untreated health issues, negatively impacting horse welfare and increasing the risk of serious health complications hampering the market growth.
Covid-19 Impact
The COVID-19 pandemic significantly accelerated the demand for service robotics across various sectors. With increased emphasis on minimizing human contact and maintaining operational continuity, robots were rapidly deployed in healthcare, logistics, and disinfection services. In warehouses and retail, robots helped fulfill heightened e-commerce demands. This surge highlighted the value of robotics for efficiency and safety, driving long-term investment and innovation in service robotics post-pandemic.
The therapeutics segment is expected to be the largest during the forecast period
The therapeutics segment is estimated to be the largest, due to the increasing adoption of anti-infective drugs, vaccines, pain relievers, and regenerative therapies. This growth is driven by increased investment in disease prevention and treatment options by horse owners and facilities. Therapeutics also plays a crucial role in disease control and prevention, supporting herd health and reducing costly outbreaks.
The lyme disease segment is expected to have the highest CAGR during the forecast period
The lyme disease segment is anticipated to witness the highest CAGR during the forecast period, because lyme disease in horses requires complex diagnostic procedures, including serological assays like ELISA and confirmatory tests like Western blot or immunofluorescence assays. Advanced diagnostic tools like the Equine Lyme Multiplex Assay improve early detection and accuracy, crucial for effective treatment. Thus market growth is driven by the need for comprehensive diagnostic services and increased awareness among horse owners about Lyme disease.
Region with largest share:
Asia Pacific is expected to have the largest market share during the forecast period because the Asia Pacific, particularly China, Japan, and Australia, is experiencing a surge in equestrian sports, leading to a growing demand for equine healthcare products. This demand is driven by the growing participation in racing, show jumping, and polo, as well as the growing importance of therapeutic solutions like vaccines, anti-infectives, and supplements to address common equine health issues.
Region with highest CAGR:
North America is projected to witness the highest CAGR over the forecast period; access to expert equine doctors, clinics, and hospitals is made possible by the strong veterinary care infrastructure in North America. By providing specialized, high-quality care, this expands the market. The rising demand for horse diseases including tetanus, equine influenza, and West Nile virus is also driving a large investment in preventive treatment, including vaccines, deworming products, and supplements.
Key players in the market
Some of the key players profiled in the Equine Healthcare Market include Arthrex Inc., Boehringer Ingelheim International GmbH, Cargill, Ceva Sante Animale, Covetrus Inc., Dechra Pharmaceuticals, Elanco, Esaote SPA, Hallmarq Veterinary Imaging, Heska Corporation, IDEXX Laboratories, Inc., Kyoritsuseiyaku Corporation, Merck & Co. Inc, Neogen Corporation, Purina Animal Nutrition LLC., Vetoquinol S.A. and Zoetis
Key Developments:
In November 2024, Merck announced that Merck has entered into an exclusive global license to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova.
In October 2024, Gilead and Merck announced Phase 2 Data Showing a Treatment Switch to an Investigational Oral Once-Weekly Combination Regimen of Islatravir and Lenacapavir Maintained Viral Suppression in Adults at Week 48.
In October 2024, Cargill launched new cocoa production line in Indonesia to meet growing Asian consumers’ demand for indulgent foods. The new line brings innovation capabilities and competitiveness to customers in the bakery, ice cream and chocolate confectionery categories, as well as for the café-style beverages in foodservice.
Product Types Covered:
• Therapeutics
• Diagnostics
• Supplemental Nutrition
• Other Product Types
Animal Types Covered:
• Performance Horses
• Recreational Horses
• Working Horses
• Racehorses
• Other Animal Types
Disease Types Covered:
• Equine Influenza
• Lyme Disease
• Tetanus
• Rabies
• Equine Encephalomyelitis
• Musculoskeletal Disorders
• West Nile Virus
• Rabies
• Other Disease Types
Distribution Channels Covered:
• Veterinary Hospitals & Clinics
• E-Commerce
• Retail Pharmacies & Drug Stores
• Other Distribution Channels
End Users Covered:
• Veterinary Hospitals
• Animal Clinics
• Research Institutes
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Equine Healthcare Market, By Product Type
5.1 Introduction
5.2 Therapeutics
5.2.1 Vaccines
5.2.2 Anti-Infective Agents
5.2.3 Parasiticides
5.2.4 Anti-Inflammatory Drugs
5.3 Diagnostics
5.3.1 Clinical Pathology
5.3.2 Immunoassays
5.3.3 Molecular Diagnostics
5.3.4 Imaging Techniques
5.4 Supplemental Nutrition
5.4.1 Feed Additives
5.4.2 Performance Supplements
5.5 Other Product Types
6 Global Equine Healthcare Market, By Animal Type
6.1 Introduction
6.2 Performance Horses
6.3 Recreational Horses
6.4 Working Horses
6.5 Racehorses
6.6 Other Animal Types
7 Global Equine Healthcare Market, By Disease Type
7.1 Introduction
7.2 Equine Influenza
7.3 Lyme Disease
7.4 Tetanus
7.5 Rabies
7.6 Equine Encephalomyelitis
7.7 Musculoskeletal Disorders
7.8 West Nile Virus
7.9 Rabies
7.10 Other Disease Types
8 Global Equine Healthcare Market, By Distribution Channel
8.1 Introduction
8.2 Veterinary Hospitals & Clinics
8.3 E-Commerce
8.4 Retail Pharmacies & Drug Stores
8.5 Other Distribution Channels
9 Global Equine Healthcare Market, By End User
9.1 Introduction
9.2 Veterinary Hospitals
9.3 Animal Clinics
9.4 Research Institutes
9.5 Other End Users
10 Global Equine Healthcare Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa
11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 Company Profiling
12.1 Arthrex Inc.
12.2 Boehringer Ingelheim International GmbH
12.3 Cargill
12.4 Ceva Sante Animale
12.5 Covetrus Inc.
12.6 Dechra Pharmaceuticals
12.7 Elanco
12.8 Esaote SPA
12.9 Hallmarq Veterinary Imaging
12.10 Heska Corporation
12.11 IDEXX Laboratories, Inc.
12.12 Kyoritsuseiyaku Corporation
12.13 Merck & Co. Inc
12.14 Neogen Corporation
12.15 Purina Animal Nutrition LLC.
12.16 Vetoquinol S.A.
12.17 Zoetis
List of Tables
1 Global Equine Healthcare Market Outlook, By Region (2022-2030) ($MN)
2 Global Equine Healthcare Market Outlook, By Product Type
(2022-2030) ($MN)
3 Global Equine Healthcare Market Outlook, By Therapeutics (2022-2030) ($MN)
4 Global Equine Healthcare Market Outlook, By Vaccines (2022-2030) ($MN)
5 Global Equine Healthcare Market Outlook, By Anti-Infective Agents (2022-2030) ($MN)
6 Global Equine Healthcare Market Outlook, By Parasiticides (2022-2030) ($MN)
7 Global Equine Healthcare Market Outlook, By Anti-Inflammatory Drugs (2022-2030) ($MN)
8 Global Equine Healthcare Market Outlook, By Diagnostics (2022-2030) ($MN)
9 Global Equine Healthcare Market Outlook, By Clinical Pathology (2022-2030) ($MN)
10 Global Equine Healthcare Market Outlook, By Immunoassays (2022-2030) ($MN)
11 Global Equine Healthcare Market Outlook, By Molecular Diagnostics (2022-2030) ($MN)
12 Global Equine Healthcare Market Outlook, By Imaging Techniques (2022-2030) ($MN)
13 Global Equine Healthcare Market Outlook, By Supplemental Nutrition (2022-2030) ($MN)
14 Global Equine Healthcare Market Outlook, By Feed Additives (2022-2030) ($MN)
15 Global Equine Healthcare Market Outlook, By Performance Supplements (2022-2030) ($MN)
16 Global Equine Healthcare Market Outlook, By Other Product Types (2022-2030) ($MN)
17 Global Equine Healthcare Market Outlook, By Animal Type (2022-2030) ($MN)
18 Global Equine Healthcare Market Outlook, By Performance Horses (2022-2030) ($MN)
19 Global Equine Healthcare Market Outlook, By Recreational Horses (2022-2030) ($MN)
20 Global Equine Healthcare Market Outlook, By Working Horses (2022-2030) ($MN)
21 Global Equine Healthcare Market Outlook, By Racehorses (2022-2030) ($MN)
22 Global Equine Healthcare Market Outlook, By Other Animal Types (2022-2030) ($MN)
23 Global Equine Healthcare Market Outlook, By Disease Type (2022-2030) ($MN)
24 Global Equine Healthcare Market Outlook, By Equine Influenza (2022-2030) ($MN)
25 Global Equine Healthcare Market Outlook, By Lyme Disease (2022-2030) ($MN)
26 Global Equine Healthcare Market Outlook, By Tetanus (2022-2030) ($MN)
27 Global Equine Healthcare Market Outlook, By Rabies (2022-2030) ($MN)
28 Global Equine Healthcare Market Outlook, By Equine Encephalomyelitis (2022-2030) ($MN)
29 Global Equine Healthcare Market Outlook, By Musculoskeletal Disorders (2022-2030) ($MN)
30 Global Equine Healthcare Market Outlook, By West Nile Virus (2022-2030) ($MN)
31 Global Equine Healthcare Market Outlook, By Rabies (2022-2030) ($MN)
32 Global Equine Healthcare Market Outlook, By Other Disease Types (2022-2030) ($MN)
33 Global Equine Healthcare Market Outlook, By Distribution Channel (2022-2030) ($MN)
34 Global Equine Healthcare Market Outlook, By Veterinary Hospitals & Clinics (2022-2030) ($MN)
35 Global Equine Healthcare Market Outlook, By E-Commerce (2022-2030) ($MN)
36 Global Equine Healthcare Market Outlook, By Retail Pharmacies & Drug Stores (2022-2030) ($MN)
37 Global Equine Healthcare Market Outlook, By Other Distribution Channels (2022-2030) ($MN)
38 Global Equine Healthcare Market Outlook, By End User (2022-2030) ($MN)
39 Global Equine Healthcare Market Outlook, By Veterinary Hospitals (2022-2030) ($MN)
40 Global Equine Healthcare Market Outlook, By Animal Clinics (2022-2030) ($MN)
41 Global Equine Healthcare Market Outlook, By Research Institutes (2022-2030) ($MN)
42 Global Equine Healthcare Market Outlook, By Other End Users (2022-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
